The emerging model suggests that the T cell cytokine IL-17 directs synovial stromal cells to utilize glutamine instead of glucose, implicating metabolic regulation in the coordination of innate and adaptive immune responses in RA. The gene discussed is IL17A; the disease is rheumatoid arthritis.